p53 protein levels and activity are induced in the brain of HD patients and in cell and mouse models of HD33, explaining at least in part, the low tumor incidence observed in HD patients (Sørensen et al., 1999; Bae et al., 2005). The gene discussed is TP53; the disease is Huntington disease.